MDWD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
MediWound Ltd (MDWD) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators are bearish, options data suggests cautious sentiment, and the financial performance shows significant net income and EPS declines. While analysts have raised the price target and the company is expanding its manufacturing capacity, these catalysts are long-term and do not justify an immediate buy given the current market conditions.
The technical indicators for MDWD are bearish. The MACD is below 0 and negatively expanding, the RSI is neutral at 35.687, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The current price is near the support level of 17.137, with resistance levels at 18.29 and 18.647.
Analysts have raised the price target from $31 to $36 and maintained a Buy rating. The company's new manufacturing facility with six-fold increased capacity is expected to begin commercial production in mid-2026, which could drive long-term growth.
No significant hedge fund or insider trading activity. The financial performance shows a steep decline in net income (-74.21% YoY) and EPS (-75.51% YoY). Technical indicators are bearish, and options data suggests cautious sentiment.
In Q3 2025, revenue increased by 24.66% YoY to $5,429,000, but net income dropped significantly to -$2,652,000 (-74.21% YoY) and EPS fell to -0.24 (-75.51% YoY). Gross margin improved slightly to 16.5% (+6.11% YoY).
H.C. Wainwright raised the price target from $31 to $36 and maintained a Buy rating. Analysts are optimistic about the company's long-term growth potential due to its new manufacturing facility.
